Glitaray M 2mg/500mg Tablet
Marketer
Lloyd Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glitaray M 2mg/500mg Tablet
Diabex Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol should be avoided due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor. Regular blood glucose monitoring and potential blood tests (blood cell counts and liver function) will be necessary as directed by your physician.
Primary Ingredients of Glitaray M 2mg/500mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glitaray M 2mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Glitaray M 2mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Glitaray M 2mg/500mg Tablet should be administered with food.
Common Side effects of Glitaray M 2mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glitaray M 2mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glitaray M 2mg/500mg Tablet should be administered with a meal.
How Glitaray M 2mg/500mg Tablet works:
Glitaray M, a 2mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glitaray M 2mg/500mg Tablet and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glitaray M 2mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Breastfeeding while taking Glitaray M 2mg/500mg tablets is contraindicated due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glitaray M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glitaray M 2mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Individuals with liver impairment should use Glitaray M 2mg/500mg tablets cautiously, potentially requiring dosage modifications. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glitaray M 2mg/500mg Tablet :
Should you forget a dose of Glitaray M 2mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glitaray M 2mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |






